• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心脏植入式电子装置及经三尖瓣导线患者行经导管三尖瓣修复术的可行性和疗效

Feasibility and Efficacy of Transcatheter Tricuspid Valve Repair in Patients with Cardiac Implanted Electrical Devices and Trans-Tricuspid Leads.

作者信息

Alachkar Mhd Nawar, Schnupp Steffen, Eichelsdoerfer Astrid, Milzi Andrea, Mady Hesham, Salloum Basem, Bisht Osama, Cheikh-Ibrahim Mohammed, Forkmann Mathias, Krygier Lukas, Mahnkopf Christian

机构信息

Department of Cardiology and Angiology, Regiomed Klinikum Coburg, 3396450 Coburg, Germany.

Department of Cardiology, Istituto Cardiocentro Ticino, 6900 Lugano, Switzerland.

出版信息

J Clin Med. 2023 Jul 27;12(15):4930. doi: 10.3390/jcm12154930.

DOI:10.3390/jcm12154930
PMID:37568330
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10420306/
Abstract

BACKGROUND

Transcatheter tricuspid valve repair using the edge-to-edge-technique (TEER) has emerged as an alternative therapy in patients with severe tricuspid regurgitation (TR) and high surgical risk. This study aimed to evaluate the feasibility and efficacy of tricuspid valve TEER in patients with cardiac implanted electric devices (CIEDs).

METHODS

All patients who underwent tricuspid valve TEER at our center were retrospectively included. Patients were classified according to the presence of CIEDs. Procedure success was defined as implantation of at least one clip and the reduction of TR of at least one grade. Procedure success and intrahospital outcome were compared between the two groups.

RESULTS

One-hundred and six consecutive patients underwent tricuspid TEER (age 80.1 ± 6.4 years, male = 42; 39.6%). Among them, 25 patients (23.6%, age 80.6 ± 7.3 years, male = 14; 56%) had CIEDs. Patients with CIEDs had a significantly lower left ventricular ejection fraction (LV-EF) compared to those without CIEDs (47.2 ± 15% vs. 56.2 ± 8.2%, = 0.004, respectively). Moreover, arterial hypertension was more common in patients with CIEDs (96% vs. 79%, = 0.048). The success of the procedure did not differ between the non-CIED vs. CIED group (93.8% vs. 92%, = 0.748). Furthermore, the number and position of implanted clips, the duration of the procedure, the post-procedural pressure gradient across the tricuspid valve, and post-procedural TR severity were comparable between both groups.

CONCLUSION

Tricuspid valve TEER is feasible and efficient in patients with CIEDs. The success of the procedure, as well as the intrahospital outcome were comparable between patients with and without CIEDs.

摘要

背景

使用边对边技术(TEER)的经导管三尖瓣修复术已成为严重三尖瓣反流(TR)且手术风险高的患者的一种替代治疗方法。本研究旨在评估心脏植入电子设备(CIED)患者进行三尖瓣TEER的可行性和疗效。

方法

回顾性纳入在我们中心接受三尖瓣TEER的所有患者。根据是否存在CIED对患者进行分类。手术成功定义为植入至少一个夹子且TR降低至少一个等级。比较两组之间的手术成功率和院内结局。

结果

106例连续患者接受了三尖瓣TEER(年龄80.1±6.4岁,男性42例;占39.6%)。其中,25例患者(23.6%,年龄80.6±7.3岁,男性14例;占56%)有CIED。与没有CIED的患者相比,有CIED的患者左心室射血分数(LV-EF)显著更低(分别为47.2±15%和56.2±8.2%,P = 0.004)。此外,CIED患者中动脉高血压更常见(96%对79%,P = 0.048)。非CIED组与CIED组之间手术成功率无差异(93.8%对92%,P = 0.748)。此外,两组之间植入夹子的数量和位置、手术持续时间、术后三尖瓣跨瓣压力梯度以及术后TR严重程度相当。

结论

CIED患者进行三尖瓣TEER是可行且有效的。有CIED和没有CIED的患者之间手术成功率以及院内结局相当。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/160a/10420306/6401cfffcf06/jcm-12-04930-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/160a/10420306/6401cfffcf06/jcm-12-04930-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/160a/10420306/6401cfffcf06/jcm-12-04930-g001.jpg

相似文献

1
Feasibility and Efficacy of Transcatheter Tricuspid Valve Repair in Patients with Cardiac Implanted Electrical Devices and Trans-Tricuspid Leads.心脏植入式电子装置及经三尖瓣导线患者行经导管三尖瓣修复术的可行性和疗效
J Clin Med. 2023 Jul 27;12(15):4930. doi: 10.3390/jcm12154930.
2
Surgical treatment of tricuspid valve regurgitation in patients with cardiac implantable electronic devices: long-term results.心脏植入式电子设备患者三尖瓣反流的外科治疗:长期结果。
Eur J Cardiothorac Surg. 2022 Aug 3;62(3). doi: 10.1093/ejcts/ezac239.
3
Outcomes of TTVI in Patients With Pacemaker or Defibrillator Leads: Data From the TriValve Registry.经导管二尖瓣置换术治疗伴有起搏器或除颤器导线患者的结局:来自三尖瓣注册研究的数据。
JACC Cardiovasc Interv. 2020 Mar 9;13(5):554-564. doi: 10.1016/j.jcin.2019.10.058. Epub 2020 Jan 15.
4
Predictors of Procedural and Clinical Outcomes in Patients With Symptomatic Tricuspid Regurgitation Undergoing Transcatheter Edge-to-Edge Repair.经导管缘对缘修复术治疗症状性三尖瓣反流患者的操作和临床结局的预测因素。
JACC Cardiovasc Interv. 2018 Jun 25;11(12):1119-1128. doi: 10.1016/j.jcin.2018.05.002.
5
Compassionate Use of the PASCAL Transcatheter Valve Repair System for Severe Tricuspid Regurgitation: A Multicenter, Observational, First-in-Human Experience.经导管 PASCAL 瓣膜修复系统治疗重度三尖瓣反流的同情使用:多中心、观察性、首例人体经验。
JACC Cardiovasc Interv. 2019 Dec 23;12(24):2488-2495. doi: 10.1016/j.jcin.2019.09.046.
6
Combined Tricuspid and Mitral Versus Isolated Mitral Valve Repair for Severe MR and TR: An Analysis From the TriValve and TRAMI Registries.三尖瓣和二尖瓣联合修复与单纯二尖瓣修复治疗重度 MR 和 TR:来自 TriValve 和 TRAMI 注册研究的分析。
JACC Cardiovasc Interv. 2020 Mar 9;13(5):543-550. doi: 10.1016/j.jcin.2019.10.023. Epub 2020 Jan 15.
7
Reduction in Right Atrial Pressures Is Associated With Hemodynamic Improvements After Transcatheter Edge-to-Edge Repair of the Tricuspid Valve.经导管缘对缘修复三尖瓣后右心房压力降低与血液动力学改善相关。
Circ Cardiovasc Interv. 2021 Dec;14(12):e010557. doi: 10.1161/CIRCINTERVENTIONS.121.010557. Epub 2021 Nov 24.
8
Outcomes After Current Transcatheter Tricuspid Valve Intervention: Mid-Term Results From the International TriValve Registry.经导管三尖瓣介入治疗后的结局:国际三尖瓣注册研究的中期结果。
JACC Cardiovasc Interv. 2019 Jan 28;12(2):155-165. doi: 10.1016/j.jcin.2018.10.022. Epub 2018 Dec 26.
9
Right Ventricular Cardiac Power Index Predicts 1 Year Outcome After Transcatheter Edge-to-Edge-Repair for Severe Tricuspid Valve Regurgitation.经导管缘对缘修复术治疗重度三尖瓣反流 1 年后右心室心搏量指数预测结果。
Am J Cardiol. 2023 Sep 1;202:182-191. doi: 10.1016/j.amjcard.2023.06.071. Epub 2023 Jul 12.
10
Transcatheter treatment of severe tricuspid regurgitation using the edge-to-edge repair technique.经导管使用边对边修复技术治疗严重三尖瓣反流。
EuroIntervention. 2017 Feb 3;12(15):e1837-e1844. doi: 10.4244/EIJ-D-16-00949.

引用本文的文献

1
Cardiac implantable electronic device carriers undergoing transcatheter tricuspid valve annuloplasty: real-world insights.接受经导管三尖瓣环成形术的心脏植入式电子设备携带者:真实世界的见解
Clin Res Cardiol. 2025 Mar 10. doi: 10.1007/s00392-025-02616-5.
2
Key Imaging Factors for Transcatheter Management of Tricuspid Regurgitation: Device and Patient Selection.经导管治疗三尖瓣反流的关键影像因素:器械及患者选择
J Clin Med. 2024 Oct 15;13(20):6144. doi: 10.3390/jcm13206144.

本文引用的文献

1
Transcatheter Repair for Patients with Tricuspid Regurgitation.经导管三尖瓣反流修复术治疗患者。
N Engl J Med. 2023 May 18;388(20):1833-1842. doi: 10.1056/NEJMoa2300525. Epub 2023 Mar 4.
2
Transcatheter tricuspid valve intervention techniques and procedural steps for the treatment of tricuspid regurgitation: a review of the literature.经导管三尖瓣介入治疗技术及程序步骤治疗三尖瓣反流:文献复习。
Open Heart. 2022 Jun;9(1). doi: 10.1136/openhrt-2022-002030.
3
2021 ESC/EACTS Guidelines for the management of valvular heart disease.
2021年欧洲心脏病学会/欧洲心胸外科学会瓣膜性心脏病管理指南。
Eur Heart J. 2022 Feb 12;43(7):561-632. doi: 10.1093/eurheartj/ehab395.
4
Transcatheter Edge-to-Edge Repair for Treatment of Tricuspid Regurgitation.经导管缘对缘修复术治疗三尖瓣反流。
J Am Coll Cardiol. 2021 Jan 26;77(3):229-239. doi: 10.1016/j.jacc.2020.11.038.
5
Safety and Efficacy of Transcatheter Edge-to-Edge Repair of the Tricuspid Valve in Patients With Cardiac Implantable Electronic Device Leads.心脏植入式电子设备导线患者三尖瓣经导管缘对缘修复的安全性和有效性
JACC Cardiovasc Interv. 2019 Oct 28;12(20):2114-2116. doi: 10.1016/j.jcin.2019.05.034.
6
Incidence and predictors of pacemaker induced cardiomyopathy: A single-center experience.起搏器诱发的心肌病的发病率及预测因素:单中心经验
J Electrocardiol. 2019 Nov-Dec;57:31-34. doi: 10.1016/j.jelectrocard.2019.08.016. Epub 2019 Aug 23.
7
Implantable Cardiac Electronic Devices in the Elderly Population.老年人群中的植入式心脏电子设备
Arrhythm Electrophysiol Rev. 2019 May;8(2):143-146. doi: 10.15420/aer.2019.3.4.
8
Outcomes After Current Transcatheter Tricuspid Valve Intervention: Mid-Term Results From the International TriValve Registry.经导管三尖瓣介入治疗后的结局:国际三尖瓣注册研究的中期结果。
JACC Cardiovasc Interv. 2019 Jan 28;12(2):155-165. doi: 10.1016/j.jcin.2018.10.022. Epub 2018 Dec 26.
9
Tricuspid regurgitation is associated with increased mortality independent of pulmonary pressures and right heart failure: a systematic review and meta-analysis.三尖瓣反流与死亡率升高相关,与肺压和右心衰竭无关:系统评价和荟萃分析。
Eur Heart J. 2019 Feb 1;40(5):476-484. doi: 10.1093/eurheartj/ehy641.
10
Clinical presentation and outcome of tricuspid regurgitation in patients with systolic dysfunction.收缩功能障碍患者三尖瓣反流的临床表现和转归。
Eur Heart J. 2018 Oct 14;39(39):3584-3592. doi: 10.1093/eurheartj/ehy434.